Stat3 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| STAT3 Protein | |
|---|---|
| Protein Name | Signal Transducer and Activator of Transcription 3 |
| Gene | STAT3 |
| UniProt ID | P40763 |
| PDB IDs | 1BG1, 1OZ1, 2TSS |
| Molecular Weight | 92.0 kDa |
| Subcellular Localization | Cytoplasm, Nucleus |
| Protein Family | STAT family |
The STAT3 protein is a transcription factor that mediates cellular responses to cytokines and growth factors. Upon phosphorylation at tyrosine 705, STAT3 dimerizes and translocates to the nucleus where it activates target gene transcription. In the central nervous system, STAT3 regulates genes involved in inflammation, cell survival, and differentiation. STAT3 is activated in astrocytes and microglia in response to neuroinflammation and plays complex, context-dependent roles in neurodegeneration - exhibiting both pro-survival and pro-inflammatory properties depending on the cellular environment and disease stage.
STAT3 is a transcription factor that mediates cellular responses to cytokines and growth factors, regulating genes involved in cell survival, proliferation, and immune responses.
STAT3 is a 770-amino acid protein with an N-terminal coiled-coil domain (residues 1-320) for protein-protein interactions, a DNA-binding domain (DBD, residues 320-480), a linker domain, an SH2 domain for dimerization (residues 580-680), and a C-terminal transactivation domain (TAD, residues 680-770). The TAD contains a critical tyrosine residue (Y705) that is phosphorylated for activation.
STAT3 is activated by phosphorylation at Y705 by JAK kinases in response to cytokines (IL-6, LIF, CNTF) and growth factors (EGF, PDGF). Phosphorylated STAT3 dimerizes via reciprocal SH2 domain interactions and translocates to the nucleus to activate target genes. STAT3 regulates inflammatory responses, cell survival (via Bcl-2, Mcl-1), and differentiation. In the CNS, STAT3 has complex roles - neuroprotective in some contexts but promoting neuroinflammation in others.
STAT3 is implicated in AD (neuroinflammation), PD (dopaminergic neuron survival), ALS (neuroinflammation), and MS (autoimmune demyelination). STAT3 mutations cause hyper-IgE syndrome. Constitutive STAT3 activation is seen in many cancers.
STAT3 inhibitors include peptide inhibitors, small molecules (e.g., Napabucasin), and natural products. IL-6 receptor antibodies (tocilizumab) indirectly inhibit STAT3 activation. These are primarily in cancer trials. In neurodegeneration, modulating STAT3 rather than complete inhibition may be beneficial.
The study of Stat3 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.